Cortexyme, Inc. (QNCX) Misses Q3 EPS by 3c

Cortexyme, Inc. (NASDAQ: QNCX) reported Q3 EPS of ($0.25), $0.03 worse than the analyst estimate of ($0.22).

For earnings history and earnings-related data on Cortexyme, Inc. (QNCX) click here.

You May Also Be Interested In

• Klarna (KLAR) Reiterated at Market Perform by Citizens Amid Volume Headwinds
• Jefferies Downgrades Alfen (ALFEN:NA) (ALFNF) to Hold
• Bicara Therapeutics (BCAX) Reiterated at Market Outperform by Citizens as Pivotal Trial Advances